We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.01B
AUM Growth
+$51.4M
Cap. Flow
+$4.67M
Cap. Flow %
0.46%
Top 10 Hldgs %
30.68%
Holding
182
New
9
Increased
47
Reduced
78
Closed
1

Top Buys

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$2.01M
2
ALC icon
Alcon
ALC
+$1.1M
3
CTSH icon
Cognizant
CTSH
+$1.02M
4
ABB
ABB Ltd
ABB
+$986K
5
USB icon
US Bancorp
USB
+$917K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.21M
2
NVS icon
Novartis
NVS
+$1.19M
3
MSFT icon
Microsoft
MSFT
+$815K
4
DOX icon
Amdocs
DOX
+$732K
5
RTX icon
RTX Corp
RTX
+$648K

Sector Composition

Rank Sector Weight
1 Technology 25.56%
2 Healthcare 16.99%
3 Financials 12.14%
4 Consumer Staples 10.6%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
26
Weyerhaeuser
WY
$17.6B
$14.3M 1.42%
544,340
+23,123
+4% +$588K
CB icon
27
Chubb
CB
$141B
$14.3M 1.41%
96,842
+4,708
+5% +$680K
TRMB icon
28
Trimble
TRMB
$13.7B
$13.7M 1.36%
304,102
+8,938
+3% +$371K
SNPS icon
29
Synopsys
SNPS
$73.3B
$13.7M 1.35%
106,299
-2,364
-2% -$284K
WLY icon
30
John Wiley & Sons Class A
WLY
$2.84B
$13.6M 1.34%
296,293
+6,763
+2% +$308K
JNJ icon
31
Johnson & Johnson
JNJ
$644B
$13.5M 1.34%
97,207
-1,060
-1% -$147K
FDX icon
32
FedEx
FDX
$73.4B
$13.5M 1.34%
82,419
+1,849
+2% +$324K
RDS.B
33
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$13.5M 1.34%
205,589
+6,072
+3% +$395K
UN
34
DELISTED
Unilever NV New York Registry Shares
UN
$13.2M 1.3%
217,389
-3,184
-1% -$191K
SNY icon
35
Sanofi
SNY
$108B
$12.7M 1.26%
293,539
+9,850
+3% +$419K
NVS icon
36
Novartis
NVS
$301B
$11.3M 1.11%
123,353
-14,095
-10% -$1.19M
GILD icon
37
Gilead Sciences
GILD
$167B
$11.2M 1.11%
165,714
+8,314
+5% +$547K
GLW icon
38
Corning
GLW
$107B
$10.9M 1.08%
327,685
+55
+0% +$1.76K
PPG icon
39
PPG Industries
PPG
$24.8B
$10.9M 1.07%
92,992
+6,060
+7% +$691K
AMAT icon
40
Applied Materials
AMAT
$356B
$10.7M 1.06%
239,002
-2,300
-1% -$96.8K
UL icon
41
Unilever
UL
$143B
$10.5M 1.04%
151,090
+3,147
+2% +$214K
CVX icon
42
Chevron
CVX
$382B
$10M 0.99%
80,420
-2,426
-3% -$293K
BC icon
43
Brunswick
BC
$5.21B
$9.7M 0.96%
211,276
+10,391
+5% +$502K
FLIR
44
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$9.38M 0.93%
173,312
+7,584
+5% +$385K
CTSH icon
45
Cognizant
CTSH
$26.5B
$9.02M 0.89%
142,273
+15,580
+12% +$1.02M
ALB icon
46
Albemarle
ALB
$13.4B
$8.76M 0.87%
124,463
+9,880
+9% +$729K
MDLZ icon
47
Mondelez International
MDLZ
$83.7B
$7.58M 0.75%
140,600
-2,178
-2% -$113K
TMO icon
48
Thermo Fisher Scientific
TMO
$213B
$7.52M 0.74%
25,618
-468
-2% -$129K
BRK.A icon
49
Berkshire Hathaway Class A
BRK.A
$1.1T
$7M 0.69%
22
ECL icon
50
Ecolab
ECL
$78.9B
$6.42M 0.63%
32,520
-425
-1% -$79K

Similar funds

Grandfield & Dodd's Q2 2019 Portfolio in Review

As of Q2 2019, Grandfield & Dodd held 182 positions worth $1.01B, up 5.4% from $960M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q2 2019 filing shows 9 new, 47 increased, 78 reduced and 1 closed positions. Its largest new stake was Alcon: 18,816 shares worth $1.17M. The largest sale was Merck, an estimated $1.21M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q2 2019 buy was Alcon: 18,816 shares worth $1.17M.
  • Grandfield & Dodd added most to Blackbaud in Q2 2019, an estimated $2.01M increase.
  • Grandfield & Dodd's biggest Q2 2019 reduction was Merck, cutting an estimated $1.21M.
  • Grandfield & Dodd fully exited Vanguard FTSE Europe ETF in Q2 2019, selling an estimated $218K.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $1.01B portfolio in Q2 2019.
  • Grandfield & Dodd opened 9 new positions and closed 1 in Q2 2019.
  • Grandfield & Dodd's portfolio value rose 5.4% quarter-over-quarter to $1.01B.

Based on Grandfield & Dodd's 13F filing for Q2 2019, filed 29 Jul 2019.